Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Tadaaki, T"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 198
Tytuł:
Mesothelin expression in gynecologic carcinosarcoma: clinicopathological significance and correlation with HER2 expression.
Autorzy:
Kitadai R; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Nishikawa T; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Yoshida H; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
Mizoguchi C; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Yamamoto K; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Kato T; Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan.
Yonemori K; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. .
Pokaż więcej
Źródło:
Journal of gynecologic oncology [J Gynecol Oncol] 2024 Mar; Vol. 35 (2), pp. e11. Date of Electronic Publication: 2023 Oct 12.
Typ publikacji:
Journal Article
MeSH Terms:
Uterine Neoplasms*/pathology
Ovarian Neoplasms*/pathology
Carcinosarcoma*/pathology
Humans ; Female ; Mesothelin ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Totally endoscopic concomitant aortic and mitral valve surgery in junctional epidermolysis bullosa: a case report.
Autorzy:
Yoshida K; Department of Cardiovascular Surgery, Kobe City Medical Center General Hospital, 2-1-1 Minatojimaminamimachi, Chuo-ku, Kobe, 650-0047, Japan. .
Yoshida S; Department of Cardiovascular Surgery, Kobe City Medical Center General Hospital, 2-1-1 Minatojimaminamimachi, Chuo-ku, Kobe, 650-0047, Japan.
Hori Y; Department of Cardiovascular Surgery, Kobe City Medical Center General Hospital, 2-1-1 Minatojimaminamimachi, Chuo-ku, Kobe, 650-0047, Japan.
Tsubota H; Department of Cardiovascular Surgery, Kobe City Medical Center General Hospital, 2-1-1 Minatojimaminamimachi, Chuo-ku, Kobe, 650-0047, Japan.
Mochizuki R; Department of Dermatology, Kobe City Medical Center General Hospital, Kobe, Japan.
Nagano T; Department of Dermatology, Kobe City Medical Center General Hospital, Kobe, Japan.
Koyama T; Department of Cardiovascular Surgery, Kobe City Medical Center General Hospital, 2-1-1 Minatojimaminamimachi, Chuo-ku, Kobe, 650-0047, Japan.
Pokaż więcej
Źródło:
Journal of cardiothoracic surgery [J Cardiothorac Surg] 2024 Feb 20; Vol. 19 (1), pp. 102. Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Epidermolysis Bullosa, Junctional*/complications
Cardiac Surgical Procedures*
Mitral Valve Insufficiency*/surgery
Male ; Humans ; Middle Aged ; Mitral Valve/surgery ; Blister ; Aortic Valve/surgery
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Possible nonimmunological toxicological mechanisms of vesnarinone-associated agranulocytosis in HL-60 cells: role of reduced glutathione as cytotoxic defense.
Autorzy:
Koga T; Department of Drug Metabolism and Pharmacokinetics, Nonclinical Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd.
Sahara Y; Department of Drug Metabolism and Pharmacokinetics, Nonclinical Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd.
Ohtani T; Department of Drug Metabolism and Pharmacokinetics, Nonclinical Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd.
Yosuke K; Department of Drug Metabolism and Pharmacokinetics, Nonclinical Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd.
Umehara K; Department of Drug Metabolism and Pharmacokinetics, Nonclinical Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd.
Pokaż więcej
Źródło:
The Journal of toxicological sciences [J Toxicol Sci] 2024; Vol. 49 (3), pp. 95-103.
Typ publikacji:
Journal Article
MeSH Terms:
Agranulocytosis*/chemically induced
Antineoplastic Agents*
Pyrazines*
Quinolines*
Humans ; Chloramines ; Glutathione ; HL-60 Cells ; Hydrogen Peroxide/toxicity ; Reactive Oxygen Species ; Chlorides ; Piperazines
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
MPL gene mutation is a possible risk factor for thrombosis in patients with essential thrombocythemia in Japan.
Autorzy:
Furuya C; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Hashimoto Y; Department of Hematology, Tottori Prefectural Central Hospital, Tottori City, Japan.; Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Morishita S; Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Laboratory for the Development of Therapies against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Inano T; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Ochiai T; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Laboratory for the Development of Therapies against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Shirane S; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Laboratory for the Development of Therapies against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Edahiro Y; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Laboratory for the Development of Therapies against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Araki M; Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Laboratory for the Development of Therapies against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Ando M; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Komatsu N; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Laboratory for the Development of Therapies against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan.; PharmaEssentia Japan KK, Tokyo, Japan.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2229131.
Typ publikacji:
Journal Article
MeSH Terms:
Thrombocythemia, Essential*/complications
Thrombocythemia, Essential*/genetics
Thrombosis*/genetics
Humans ; Japan/epidemiology ; Mutation ; Risk Factors ; Calreticulin/genetics ; Janus Kinase 2/genetics ; Receptors, Thrombopoietin/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
First-Line Chemoimmunotherapy versus Sequential Platinum-Based Chemotherapy Followed by Immunotherapy in Patients with Non-Small Cell Lung Cancer with ≤49% Programmed Death-Ligand 1 Expression: A Real-World Multicenter Retrospective Study.
Autorzy:
Tanimura K; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daini Hospital, Kyoto 602-8026, Japan.
Takeda T; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daini Hospital, Kyoto 602-8026, Japan.
Kataoka N; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daini Hospital, Kyoto 602-8026, Japan.
Yoshimura A; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daini Hospital, Kyoto 602-8026, Japan.
Nakanishi K; Department of Thoracic Oncology, Kansai Medical University Hospital, Hirakata 573-1191, Japan.
Yamanaka Y; Department of Thoracic Oncology, Kansai Medical University Hospital, Hirakata 573-1191, Japan.
Yoshioka H; Department of Thoracic Oncology, Kansai Medical University Hospital, Hirakata 573-1191, Japan.
Honda R; Department of Respiratory Medicine, Asahi General Hospital, Asahi 289-2511, Japan.
Uryu K; Department of Respiratory Medicine, Yao Tokushukai General Hospital, Yao 581-0011, Japan.
Fukui M; Department of Respiratory Medicine, Uji-Tokushukai Medical Center, Uji 611-0041, Japan.
Chihara Y; Department of Respiratory Medicine, Uji-Tokushukai Medical Center, Uji 611-0041, Japan.
Takei S; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Kawachi H; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Yamada T; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Tamiya N; Department of Respiratory Medicine, Rakuwakai Otowa Hospital, Kyoto 607-8062, Japan.
Okura N; Department of Respiratory Medicine, Matsushita Memorial Hospital, Moriguchi 570-8540, Japan.
Yamada T; Department of Respiratory Medicine, Matsushita Memorial Hospital, Moriguchi 570-8540, Japan.
Murai J; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto 605-0981, Japan.
Shiotsu S; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto 605-0981, Japan.
Kurata T; Department of Thoracic Oncology, Kansai Medical University Hospital, Hirakata 573-1191, Japan.
Takayama K; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 Oct 14; Vol. 15 (20). Date of Electronic Publication: 2023 Oct 14.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of beta-tricalcium phosphate on preventing tooth extraction-triggered bisphosphonate-related osteonecrosis of the jaw in rats.
Autorzy:
Funayama N; Department of Oral and Maxillofacial Surgery, Nara Medical University, 840 Shijo-cho, Kashihara-shi, Nara, 634-8521, Japan.
Yagyuu T; Department of Oral and Maxillofacial Surgery, Nara Medical University, 840 Shijo-cho, Kashihara-shi, Nara, 634-8521, Japan. t.
Imada M; Department of Oral and Maxillofacial Surgery, Nara Medical University, 840 Shijo-cho, Kashihara-shi, Nara, 634-8521, Japan.
Ueyama Y; Department of Oral and Maxillofacial Surgery, Nara Medical University, 840 Shijo-cho, Kashihara-shi, Nara, 634-8521, Japan.
Nakagawa Y; Department of Oral and Maxillofacial Surgery, Nara Medical University, 840 Shijo-cho, Kashihara-shi, Nara, 634-8521, Japan.
Kirita T; Department of Oral and Maxillofacial Surgery, Nara Medical University, 840 Shijo-cho, Kashihara-shi, Nara, 634-8521, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Sep 25; Vol. 13 (1), pp. 16032. Date of Electronic Publication: 2023 Sep 25.
Typ publikacji:
Journal Article
MeSH Terms:
Bisphosphonate-Associated Osteonecrosis of the Jaw*/etiology
Bisphosphonate-Associated Osteonecrosis of the Jaw*/prevention & control
Animals ; Rats ; Humans ; Dental Care ; Tooth Extraction/adverse effects ; Calcium Phosphates ; Zoledronic Acid
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Predictive Value of Modified Glasgow Prognostic Score and Persistent Inflammation among Patients with Non-Small Cell Lung Cancer Treated with Durvalumab Consolidation after Chemoradiotherapy: A Multicenter Retrospective Study.
Autorzy:
Tanimura K; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daini Hospital, Kyoto 602-8026, Japan.
Takeda T; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daini Hospital, Kyoto 602-8026, Japan.
Yoshimura A; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daini Hospital, Kyoto 602-8026, Japan.
Honda R; Department of Respiratory Medicine, Asahi General Hospital, Asahi 289-2511, Japan.
Goda S; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto 605-0981, Japan.
Shiotsu S; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto 605-0981, Japan.
Fukui M; Department of Respiratory Medicine, Uji-Tokushukai Medical Center, Uji 611-0041, Japan.
Chihara Y; Department of Respiratory Medicine, Uji-Tokushukai Medical Center, Uji 611-0041, Japan.
Uryu K; Department of Respiratory Medicine, Yao Tokushukai General Hospital, Yao 581-0011, Japan.
Takei S; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Katayama Y; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Hibino M; Department of Respiratory Medicine, Shonan Fujisawa Tokushukai Hospital, Fujisawa 251-0041, Japan.
Yamada T; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Takayama K; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 Sep 01; Vol. 15 (17). Date of Electronic Publication: 2023 Sep 01.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Recurrence of Large-Vessel Vasculitis Induced by Multiple Types of Granulocyte Colony-Stimulating Factor Preparation in Patient with Large-Cell Neuroendocrine Lung Carcinoma: A Case Report.
Autorzy:
Seto Y; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Yamada T; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Egami M; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Sugimoto T; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Sato I; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Tanaka S; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Chihara Y; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Morimoto K; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Iwasaku M; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Tokuda S; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Kaneko Y; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Tamayama K; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Pokaż więcej
Źródło:
Case reports in oncology [Case Rep Oncol] 2023 Sep 01; Vol. 16 (1), pp. 771-778. Date of Electronic Publication: 2023 Sep 01 (Print Publication: 2023).
Typ publikacji:
Case Reports
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Endobronchial metastasis of hepatocellular carcinoma treated with Lenvatinib: A case report.
Autorzy:
Takei S; Department of Pulmonary Medicine Kyoto Prefectural University of Medicine Kyoto Japan.; Department of Respiratory Medicine Japanese Red Cross Kyoto Daini Hospital Kyoto Japan.
Yoshimura A; Department of Pulmonary Medicine Kyoto Prefectural University of Medicine Kyoto Japan.; Department of Respiratory Medicine Japanese Red Cross Kyoto Daini Hospital Kyoto Japan.
Yamamoto C; Department of Infectious Disease Kyoto Prefectural University of Medicine Kyoto Japan.
Kataoka S; Department of Molecular Gastroenterology and Hepatology Kyoto Prefectural University of Medicine Kyoto Japan.
Kataoka N; Department of Pulmonary Medicine Kyoto Prefectural University of Medicine Kyoto Japan.; Department of Respiratory Medicine Japanese Red Cross Kyoto Daini Hospital Kyoto Japan.
Morimoto K; Department of Pulmonary Medicine Kyoto Prefectural University of Medicine Kyoto Japan.
Iwasaku M; Department of Pulmonary Medicine Kyoto Prefectural University of Medicine Kyoto Japan.
Tokuda S; Department of Pulmonary Medicine Kyoto Prefectural University of Medicine Kyoto Japan.
Yamada T; Department of Pulmonary Medicine Kyoto Prefectural University of Medicine Kyoto Japan.
Takeda T; Department of Respiratory Medicine Japanese Red Cross Kyoto Daini Hospital Kyoto Japan.
Takayama K; Department of Pulmonary Medicine Kyoto Prefectural University of Medicine Kyoto Japan.
Pokaż więcej
Źródło:
Respirology case reports [Respirol Case Rep] 2023 Aug 22; Vol. 11 (9), pp. e01208. Date of Electronic Publication: 2023 Aug 22 (Print Publication: 2023).
Typ publikacji:
Case Reports
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Uterine Leiomyosarcoma Masquerading as a Malignant Perivascular Epithelioid Cell Tumor: A Diagnostic Challenge.
Autorzy:
Natsume T; Department of Gynecology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Yoshida H; Department of Diagnostic Pathology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Nishikawa T; Department of Medical Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Kikkawa N; Department of Diagnostic Radiology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Naka T; Department of Diagnostic Pathology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Kobayashi-Kato M; Department of Gynecology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Tanase Y; Department of Gynecology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Uno M; Department of Gynecology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Ishikawa M; Department of Gynecology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Kato T; Department of Gynecology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2023 Aug; Vol. 31 (5), pp. 778-784. Date of Electronic Publication: 2022 Oct 31.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Leiomyosarcoma*/diagnosis
Leiomyosarcoma*/genetics
Leiomyosarcoma*/pathology
Vaginal Neoplasms*
Uterine Neoplasms*/diagnosis
Uterine Neoplasms*/genetics
Neuroendocrine Tumors*
Perivascular Epithelioid Cell Neoplasms*/diagnosis
Perivascular Epithelioid Cell Neoplasms*/genetics
Perivascular Epithelioid Cell Neoplasms*/pathology
Female ; Humans ; Middle Aged ; Hysterectomy ; Biomarkers, Tumor/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Quantitative Threshold Determination of Auditory Brainstem Responses in Mouse Models.
Autorzy:
Tanaka K; Division of Materials and Manufacturing Science, Graduate School of Engineering, Osaka University, Suita 565-0871, Japan.
Ohara S; Division of Materials and Manufacturing Science, Graduate School of Engineering, Osaka University, Suita 565-0871, Japan.
Matsuzaka T; Division of Materials and Manufacturing Science, Graduate School of Engineering, Osaka University, Suita 565-0871, Japan.
Matsugaki A; Division of Materials and Manufacturing Science, Graduate School of Engineering, Osaka University, Suita 565-0871, Japan.
Ishimoto T; Division of Materials and Manufacturing Science, Graduate School of Engineering, Osaka University, Suita 565-0871, Japan.
Ozasa R; Division of Materials and Manufacturing Science, Graduate School of Engineering, Osaka University, Suita 565-0871, Japan.
Kuroda Y; Laboratory of Cell and Tissue Biology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Matsuo K; Laboratory of Cell and Tissue Biology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Nakano T; Division of Materials and Manufacturing Science, Graduate School of Engineering, Osaka University, Suita 565-0871, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jul 13; Vol. 24 (14). Date of Electronic Publication: 2023 Jul 13.
Typ publikacji:
Journal Article
MeSH Terms:
Evoked Potentials, Auditory, Brain Stem*/physiology
Hearing*/physiology
Mice ; Animals ; Acoustic Stimulation ; Auditory Threshold/physiology ; Disease Models, Animal
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy.
Autorzy:
Watanabe S; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan.; Division of Cancer Immunology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center East, 5-1, Kashiwanoha 6, Kashiwa, Chiba, 277-8577, Japan.
Shimoi T; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan. .
Nishikawa T; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan.
Kawachi A; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan.
Okuma HS; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan.
Tokura M; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan.
Yazaki S; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan.
Mizoguchi C; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan.
Arakaki M; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan.
Saito A; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan.
Kita S; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan.
Yamamoto K; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan.
Kojima Y; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan.
Sudo K; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan.
Noguchi E; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan.
Yoshida A; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan.
Kawai A; Department of Musculoskeletal Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan.
Fujiwara Y; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan.
Yonemori K; Department of Medical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5, Chuo-ku, Tokyo, 104-0045, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Jul 03; Vol. 13 (1), pp. 10734. Date of Electronic Publication: 2023 Jul 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Soft Tissue Neoplasms*/pathology
Sarcoma*/pathology
Humans ; Prognosis ; Monocytes ; Tumor Microenvironment ; Lymphocytes ; Doxorubicin/therapeutic use ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prophylactic treatment of dacomitinib-induced skin toxicities in epidermal growth factor receptor-mutated non-small-cell lung cancer: A multicenter, Phase II trial.
Autorzy:
Iwasaku M; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Uchino J; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Chibana K; Department of Respiratory Medicine, National Hospital Organization Okinawa National Hospital, Okinawa, Japan.
Tanzawa S; Division of Medical Oncology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Yamada T; Department of Pulmonary Medicine, Matsushita Memorial Hospital, Osaka, Japan.
Tobino K; Department of Respiratory Medicine, Iizuka Hospital, Iizuka, Japan.
Uchida Y; Division of Respiratory Medicine, Department of Internal Medicine, Shiga University of Medical Science, Japan.
Kijima T; Department of Respiratory Medicine and Hematology, Hyogo Medical University, School of Medicine, Hyogo, Japan.
Nakatomi K; Department of Respiratory Medicine, National Hospital Organization Ureshino Medical Center, Ureshino, Japan.
Izumi M; Department of Respiratory Medicine, National Hospital Organization, Omuta National Hospital, Fukuoka, Japan.
Tamiya N; Department of Pulmonary Medicine, Rakuwakai Otowa Hospital, Kyoto, Japan.
Kimura H; Department of Respiratory Medicine, Kanazawa University Hospital, Ishikawa, Japan.
Fujita M; Department of Respiratory Medicine, Fukuoka University Hospital, Fukuoka, Japan.
Honda R; Department of Respiratory Medicine, Asahi General Hospital, Asahi, Japan.
Takumi C; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
Yamada T; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Kaneko Y; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Kiyomi F; Statistics and Data Center, Clinical Research Support Center Kyushu, Fukuoka, Japan.
Takayama K; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Jul; Vol. 12 (14), pp. 15117-15127. Date of Electronic Publication: 2023 Jun 03.
Typ publikacji:
Clinical Trial, Phase II; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Humans ; Male ; Aged ; Female ; Prospective Studies ; Protein Kinase Inhibitors/therapeutic use ; ErbB Receptors/genetics ; Mutation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Development of a Detection System for ESR1 Mutations in Circulating Tumour DNA Using PNA-LNA-Mediated PCR Clamping.
Autorzy:
Kojima Y; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.; Division of Molecular Pharmacology, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
Noguchi E; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
Yoshino T; Department of Pharmacology and Therapeutics, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
Yagishita S; Division of Molecular Pharmacology, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
Yazaki S; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
Okuma HS; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
Nishikawa T; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
Tanioka M; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
Sudo K; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
Shimoi T; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
Kazama A; Molecular Genetic Research Department, LSI Medience Corporation, Shimura 3-30-1, Itabashi-ku, Tokyo 174-8555, Japan.
Terasaki H; Molecular Genetic Research Department, LSI Medience Corporation, Shimura 3-30-1, Itabashi-ku, Tokyo 174-8555, Japan.
Asano S; Life Technologies Japan Ltd., Thermo Fisher Scientific, Shibaura 4-2-8, Minato-ku, Tokyo 108-0023, Japan.
Fujiwara Y; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
Hamada A; Division of Molecular Pharmacology, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.; Department of Pharmacology and Therapeutics, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
Tamura K; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
Yonemori K; Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
Pokaż więcej
Źródło:
Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2023 Jun 12; Vol. 13 (12). Date of Electronic Publication: 2023 Jun 12.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Exploratory analysis of immunochemotherapy compared to chemotherapy after EGFR-TKI in non-small cell lung cancer patients with EGFR mutation: A multicenter retrospective study.
Autorzy:
Hata T; Department of Respiratory Medicine, Rakuwakai Otowa Hospital, Kyoto, Japan.
Sakaguchi C; Department of Medical Oncology, Rakuwakai Otowa Hospital, Kyoto, Japan.
Hirano K; Department of Nephrology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kobe H; Department of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, Okayama, Japan.
Ishida M; Department of Respiratory Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Nakano T; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
Tachibana Y; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
Tamiya N; Department of Respiratory Medicine, Rakuwakai Otowa Hospital, Kyoto, Japan.
Shiotsu S; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
Takeda T; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
Yamada T; Department of Respiratory Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Yokoyama T; Department of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, Okayama, Japan.
Tsuchiya M; Department of Respiratory Medicine, Rakuwakai Otowa Hospital, Kyoto, Japan.
Nagasaka Y; Department of Respiratory Medicine, Rakuwakai Otowa Hospital, Kyoto, Japan.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2023 Apr; Vol. 14 (11), pp. 1004-1011. Date of Electronic Publication: 2023 Mar 03.
Typ publikacji:
Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Humans ; Retrospective Studies ; B7-H1 Antigen ; Treatment Outcome ; ErbB Receptors ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/pharmacology ; Mutation ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of the prognosis of symptomatic cerebral infarction and pulmonary embolism in patients with advanced non-small cell lung cancer.
Autorzy:
Nakamura R; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Yamada T; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Tanaka S; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Sasada A; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
Shiotsu S; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
Tani N; Department of Pulmonary Medicine, Japan Community Health care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan.
Takeda T; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
Chihara Y; Department of Respiratory Medicine, Uji-Tokushukai Medical Center, Kyoto, Japan.
Hirai S; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Takemura Y; Department of Pulmonary Medicine, Otsu City Hospital, Shiga, Japan.
Yoshimura A; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Morimoto K; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Iwasaku M; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Tokuda S; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Kim YH; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Takayama K; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Apr; Vol. 12 (8), pp. 9097-9105. Date of Electronic Publication: 2023 Jan 27.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/complications
Lung Neoplasms*/complications
Pulmonary Embolism*/diagnosis
Pulmonary Embolism*/etiology
Humans ; Retrospective Studies ; Prognosis ; Cerebral Infarction/etiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Large-Scale Polymorphism Analysis of Dog Leukocyte Antigen Class I and Class II Genes ( DLA-88 , DLA-12/88L and DLA-DRB1 ) and Comparison of the Haplotype Diversity between Breeds in Japan.
Autorzy:
Miyamae J; Faculty of Veterinary Medicine, Okayama University of Science, 1-3 Ikoino-oka, Imabari 794-8555, Japan.
Okano M; Department of Legal Medicine, Nihon University School of Dentistry, 1-8-13 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-8310, Japan.
Katakura F; Department of Veterinary Medicine, College of Bioresource Science, Nihon University, 1866 Kameino, Fujisawa 252-0880, Japan.
Kulski JK; Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara 259-1143, Japan.
Moritomo T; Department of Veterinary Medicine, College of Bioresource Science, Nihon University, 1866 Kameino, Fujisawa 252-0880, Japan.
Shiina T; Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara 259-1143, Japan.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Mar 06; Vol. 12 (5). Date of Electronic Publication: 2023 Mar 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Genes, MHC Class II*
Histocompatibility Antigens Class I*/genetics
Dogs ; Animals ; Haplotypes ; Japan ; Leukocytes
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Age-Stratified Analysis of First-Line Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer: Real-World Evidence from a Multicenter Retrospective Study.
Autorzy:
Takeda T; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daini Hospital, Kyoto 602-8026, Japan.
Yamada T; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Kunimatsu Y; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daini Hospital, Kyoto 602-8026, Japan.
Tanimura K; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daini Hospital, Kyoto 602-8026, Japan.
Morimoto K; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Shiotsu S; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto 605-0981, Japan.
Chihara Y; Department of Respiratory Medicine, Uji-Tokushukai Medical Center, Kyoto 611-0041, Japan.
Okada A; Department of Respiratory Medicine, Saiseikai Suita Hospital, Osaka 564-0013, Japan.
Horiuchi S; Department of Respiratory Medicine, Shonan Fujisawa Tokushukai Hospital, Kanagawa 251-0041, Japan.
Hibino M; Department of Respiratory Medicine, Shonan Fujisawa Tokushukai Hospital, Kanagawa 251-0041, Japan.
Uryu K; Department of Respiratory Medicine, Yao Tokushukai General Hospital, Osaka 581-0011, Japan.
Honda R; Department of Respiratory Medicine, Asahi General Hospital, Chiba 289-2511, Japan.
Yamanaka Y; Department of Thoracic Oncology, Kansai Medical University Hospital, Osaka 573-1191, Japan.
Yoshioka H; Department of Thoracic Oncology, Kansai Medical University Hospital, Osaka 573-1191, Japan.
Kurata T; Department of Thoracic Oncology, Kansai Medical University Hospital, Osaka 573-1191, Japan.
Takayama K; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 Feb 28; Vol. 15 (5). Date of Electronic Publication: 2023 Feb 28.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Changes in HER3 expression profiles between primary and recurrent gynecological cancers.
Autorzy:
Kojima Y; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Sudo K; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Yoshida H; Department of Diagnostic Pathology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Yazaki S; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Tokura M; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Mizoguchi C; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Okuma HS; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Kita S; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Yamamoto K; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Nishikawa T; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Noguchi E; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Shimoi T; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Tanase Y; Department of Gynecology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Uno M; Department of Gynecology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Ishikawa M; Department of Gynecology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Kato T; Department of Gynecology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Koyama K; Translational Science Department I, Daiichi Sankyo Co., Ltd., 1-2-58, Hiromachi, Shinagawa-Ku, Tokyo, 140-8710, Japan.
Kobayashi M; Translational Research Department, Daiichi Sankyo RD Novare Co., Ltd., 1-16-13, Kitakasai, Edogawa-Ku, Tokyo, 134-8630, Japan.
Kakegawa T; Translational Research Department, Daiichi Sankyo RD Novare Co., Ltd., 1-16-13, Kitakasai, Edogawa-Ku, Tokyo, 134-8630, Japan.
Fujiwara Y; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Yonemori K; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan. .
Pokaż więcej
Źródło:
Cancer cell international [Cancer Cell Int] 2023 Feb 03; Vol. 23 (1), pp. 18. Date of Electronic Publication: 2023 Feb 03.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Non-driver gene mutation analysis in a large cohort of polycythemia vera and essential thrombocythemia.
Autorzy:
Morishita S; Laboratory for the Development of Therapies Against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Hashimoto Y; Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Department of Hematology, Tottori Prefectural Central Hospital, Tottori, Japan.
Furuya C; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Edahiro Y; Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Ochiai T; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Shirane S; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Inano T; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Yasuda H; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Ando M; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Araki M; Laboratory for the Development of Therapies Against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Komatsu N; Laboratory for the Development of Therapies Against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; PharmaEssentia Japan K.K., Tokyo, Japan.
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2023 Feb; Vol. 110 (2), pp. 131-136. Date of Electronic Publication: 2022 Oct 17.
Typ publikacji:
Journal Article
MeSH Terms:
Polycythemia Vera*/diagnosis
Polycythemia Vera*/genetics
Thrombocythemia, Essential*/diagnosis
Thrombocythemia, Essential*/genetics
Primary Myelofibrosis*
Humans ; Prognosis ; Mutation ; Janus Kinase 2/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 198

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies